Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 8-K Event Results of operations
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Open-market sale President and General Counsel sold 18,627 shares at an average $19.42 ($361,747)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $19.48 ($10,186)
  6. 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 830,089 shares (to pay taxes)
  7. 4 Open-market sale Director sold 7,866 shares at $18.87 ($148,430)
  8. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.96 ($9,917)
  9. 4 Open-market sale Director sold 7,862 shares at $18.34 ($144,210)
  10. 4 Open-market sale CFO, SVP & Treasurer sold 6,226 shares at $19.67 ($122,465)
  11. 4 Open-market sale Director sold 7,862 shares at $19.25 ($151,344)
  12. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.15 ($9,493)
  13. 4 Open-market sale Director sold 7,862 shares at $18.94 ($148,895)
  14. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.81 ($9,839)
  15. 4 Open-market sale Director sold 7,862 shares at $18.04 ($141,862)
  16. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $17.77 ($9,292)
  17. 4 Option exercise CEO & Chief Scientific Officer acquired 506,337 shares (option exercise)
  18. 4 Open-market sale Director sold 7,862 shares at an average $18.55 ($145,845)
  19. 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $17.93 ($9,375)
  20. 10-Q Report Quarterly Report

Page 35 of 48 · 958 filings